Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Preventing trichomoniasis and reinfection

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Prevention here is more limited than for the bacterial STIs, because the two newer biomedical tools do not apply. There is no vaccine, and doxycycline prophylaxis has no effect on a protozoan.

What is left is barriers, asking for the right test, and the part that most often fails: getting partners treated at the same time.

Related pages: Trichomoniasis · Bacterial vaginosis (BV)

The bottom line

What we know
  • Condoms reduce but do not eliminate transmission.
  • Doxy-PEP does not prevent trichomoniasis.
  • Previous infection gives no immunity.
  • Roughly one in five treated women is reinfected within three months.
What is still open
  • How much condoms reduce transmission, which is estimated rather than measured.
  • Whether a vaccine is feasible.

The story, step by step

  1. 1. Barriers ()
  2. 2. What does not work here ()
  3. 3. Testing ()
  4. 4. Breaking the loop ()
  5. 5. The vaginal environment ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

What they cover

Review of many studies

What happens

Condoms, dams and gloves, rated honestly.

What the research shows

  • Condoms used consistently reduce transmission during penile-vaginal sex, which is the main route between male and female partners.
  • They do not eliminate it, because the parasite can be present on genital skin a condom does not cover.
  • Transmission between women through vulva-to-vulva contact and shared secretions is well documented and often overlooked. Dams, cut-open condoms and gloves reduce it.
  • Shared sex toys should be covered with a fresh condom for each person, or washed thoroughly with soap and warm water between uses.
  • Water or silicone-based lubricant reduces condom breakage. Oil-based products, including petroleum jelly, damage latex.
  • The parasite does not normally infect the throat or rectum, so oral and anal sex are not significant routes.

Why it matters

Transmission between female partners is real and is the route most often left unprotected, because people assume it does not apply.

What's still uncertain

  • Condom effectiveness against trichomoniasis is estimated rather than precisely measured.

Read more

Next: What does not work here

Part 2 of 5

Doxy-PEP and vaccines

Review of many studies

What happens

Two prevention tools that do not apply.

What the research shows

  • Doxycycline post-exposure prophylaxis reduces syphilis and chlamydia, and gonorrhea to a lesser extent. It has no effect on trichomoniasis, because the parasite is a protozoan and doxycycline does not act on it.
  • Anyone relying on doxy-PEP should know it leaves this gap.
  • There is no vaccine for trichomoniasis and none in prospect.
  • Having had it and been cured confers no immunity. Reinfection on re-exposure is entirely possible and common.
  • This differs from what people expect, and it is why prevention continues after treatment.
  • Male circumcision has been associated with lower rates in some studies and is not a recommended prevention strategy for this.

Why it matters

If you take doxy-PEP, trichomoniasis is the one it does not cover. That is worth knowing rather than discovering.

What's still uncertain

  • No vaccine candidate is in development.

Read more

Next: Testing

Part 3 of 5

The part you have to ask for

Review of many studies

What happens

Screening and testing as prevention.

What the research shows

  • Trichomoniasis is often not included in a standard STI panel. Ask whether it is.
  • Annual screening is recommended for women living with HIV.
  • Targeted screening is suggested in high-prevalence settings such as STI clinics and correctional facilities.
  • Routine population screening is not recommended, and men are not routinely screened, which is a recognized gap given that men are the usual untreated reservoir.
  • Ask for NAAT rather than microscopy, since the microscope test misses a large share of infections.
  • Testing before condomless sex with a new partner is reasonable, bearing in mind that a negative test in a male partner is less reliable.

Why it matters

A clear STI screen may not have included this. One question at the appointment covers it.

What's still uncertain

  • Screening recommendations differ between guidelines.

Read more

Next: Breaking the loop

Part 4 of 5

Partner treatment

Review of many studies

What happens

The step where prevention most often fails.

What the research shows

  • All partners from the previous 60 days are treated at the same time, regardless of symptoms.
  • Most infected men have no symptoms and so are not tested or treated unless someone tells them. That is the mechanism behind most reinfections.
  • Expedited partner therapy works well here, because treatment is tablets. Ask whether it is available.
  • Both people abstain until every dose is finished and symptoms have resolved.
  • Retesting at about three months is recommended for women. Roughly one in five is reinfected within that window.
  • A new partner between treatment and symptoms returning is the other common history, and testing again is reasonable.

Why it matters

Simultaneous treatment of partners is the single most effective prevention measure for this infection.

What's still uncertain

  • Partner treatment effectiveness depends heavily on uptake.

Read more

Next: The vaginal environment

Part 5 of 5

A genuine protective factor

Review of many studies

What happens

What is supported, and what is sold.

What the research shows

  • A healthy vaginal environment is acidic, around pH 3.8 to 4.5, dominated by Lactobacillus species. That acidity is a real barrier to urogenital pathogens.
  • Douching raises vaginal pH, strips protective bacteria and is associated with increased risk of infections including this one. Not douching is a genuine preventive measure.
  • Scented sprays, washes, wipes and harsh soaps have the same effect to a lesser degree.
  • Smoking is associated with disruption of the vaginal microbiome and with bacterial vaginosis.
  • Probiotics are widely sold for maintaining vaginal flora. Evidence is limited and mixed, and they are not a substitute for the measures above.
  • Bacterial vaginosis and trichomoniasis frequently occur together, and the same practices reduce both.

Why it matters

Not douching is the clearest self-directed prevention measure here, and it is free.

What's still uncertain

  • Probiotic evidence for prevention is inconsistent.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.